Tscan Therapeutics Inc (TCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,253 | -16,156 | -48,625 | -34,425 | -18,586 |
| Depreciation Amortization | 2,402 | 1,195 | 3,328 | 2,186 | 1,130 |
| Accounts payable and accrued liabilities | 1,232 | 824 | 10 | 2,472 | 1,593 |
| Other Working Capital | -6,648 | -6,147 | -5,896 | -3,790 | -4,048 |
| Other Operating Activity | 776 | 160 | 2,506 | -740 | -746 |
| Operating Cash Flow | $-33,491 | $-20,124 | $-48,677 | $-34,297 | $-20,657 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,424 | -531 | -9,941 | -7,730 | -6,877 |
| Investing Cash Flow | $-2,424 | $-531 | $-9,941 | $-7,730 | $-6,877 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 119 | 88 | 89,938 | 89,818 | 170 |
| Other Financing Activity | 0 | 0 | 99,730 | 99,730 | 98,770 |
| Financing Cash Flow | $119 | $88 | $189,668 | $189,548 | $98,940 |
| Beginning Cash Position | 166,436 | 166,436 | 35,386 | 35,386 | 35,386 |
| End Cash Position | 130,640 | 145,869 | 166,436 | 182,907 | 106,792 |
| Net Cash Flow | $-35,796 | $-20,567 | $131,050 | $147,521 | $71,406 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,491 | -20,124 | -48,677 | -34,297 | -20,657 |
| Capital Expenditure | -2,424 | -531 | -9,941 | -7,730 | -6,877 |
| Free Cash Flow | -35,915 | -20,655 | -58,618 | -42,027 | -27,534 |